Re: Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis [2]

Journal of the National Cancer Institute

Volumn 98, Issue 21, 2006, Pages 1583-1584

  Tamborini, Elena ^a   Negri, Tiziana ^a   Miselli, Francesca ^a   Lagonigro, M Stefania ^a   Pricl, Sabrina ^b   Pilotti, Silvana ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; IMATINIB; LEUCINE; METHIONINE; STEM CELL FACTOR RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; BINDING AFFINITY; CELL STRAIN COS1; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SENSITIVITY; EXON; FIBROMATOSIS; GENE ACTIVATION; GENETIC POLYMORPHISM; GENETIC SCREENING; IMMUNOPRECIPITATION; LETTER; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PHOSPHORYLATION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

ALANINE; ANTINEOPLASTIC AGENTS; CYSTEINE; FIBROMA; HUMANS; LEUCINE; METHIONINE; MUTAGENESIS; MUTATION; PIPERAZINES; POLYMORPHISM, GENETIC; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33750580374     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj417     Document Type: Letter

References (3)

1. Goncalves A, Monges G, Yang Y, Palmerini F, Dubreuil P, Noguchi T, et al. Response of a KIT-positive extra-abdominal fi bromatosis to imatinib mesylate and KIT genetic analysis. J Natl Cancer Inst 2006;98:562-3.
2. Inokuchi K, Yamaguchi H, Tarusawa M, Futaki M, Hanawa H, Tanosaki S, et al. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia-potential clinical significance. Leukemia 2002;16:170-7.
3. Kruger S, Emig M, Lohse P, Ehninger G, Hochhaus A, Schackert HK. The c-kit (CD117) sequence variation M541L, but not N564K, is frequent in the general population, and is not associated with CML in Caucasians. Leukemia 2006;20:354-5; discussion 356-7.